Johannes A. Eble

10.3k total citations · 2 hit papers
188 papers, 7.7k citations indexed

About

Johannes A. Eble is a scholar working on Immunology and Allergy, Molecular Biology and Hematology. According to data from OpenAlex, Johannes A. Eble has authored 188 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Immunology and Allergy, 85 papers in Molecular Biology and 54 papers in Hematology. Recurrent topics in Johannes A. Eble's work include Cell Adhesion Molecules Research (94 papers), Platelet Disorders and Treatments (53 papers) and Venomous Animal Envenomation and Studies (39 papers). Johannes A. Eble is often cited by papers focused on Cell Adhesion Molecules Research (94 papers), Platelet Disorders and Treatments (53 papers) and Venomous Animal Envenomation and Studies (39 papers). Johannes A. Eble collaborates with scholars based in Germany, United Kingdom and United States. Johannes A. Eble's co-authors include Stephan Niland, Klaus Kühn, Ralph Golbik, Steve P. Watson, Flávia Rezende, Danny Tuckwell, Alice Y. Pollitt, Eladio F. Sánchez, Jörg Haier and Andreas Kern and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Johannes A. Eble

187 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The extracellular matrix in tumor progression and metastasis

2019 426 citations Johannes A. Eble, Stephan Niland profile →
Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression

2021 298 citations Stephan Niland, Johannes A. Eble et al. profile →

Peers

Countries citing papers authored by Johannes A. Eble

Since Specialization

Citations

This map shows the geographic impact of Johannes A. Eble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes A. Eble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes A. Eble more than expected).

Fields of papers citing papers by Johannes A. Eble

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes A. Eble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes A. Eble. The network helps show where Johannes A. Eble may publish in the future.

Co-authorship network of co-authors of Johannes A. Eble

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes A. Eble. A scholar is included among the top collaborators of Johannes A. Eble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes A. Eble. Johannes A. Eble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrin α2 is an early marker for osteoclast differentiation that contributes to key steps in osteoclastogenesis 2024 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), (unknown), Stephan Niland, Thomas Vogl, Johannes A. Eble	1
2	Beyond basic characterization and omics: Immunomodulatory roles of platelet‐derived extracellular vesicles unveiled by functional testing 2024 ·Journal of Extracellular Vesicles ·Mari Palviainen, (unknown), (unknown), Johannes A. Eble, (unknown), (unknown), (unknown), (unknown), Masood Kamali‐Moghaddam, Kasper Kjær-Sørensen, Claus Oxvig, Ana M. Aransay, Juan Manuel Falcón‐Pérez, Antonio Federico, Dario Greco, Saara Laitinen, Yuya Hayashi, Pia Siljander	6
3	Characterization of the molecular composition and in vitro regenerative capacity of platelet-based bioproducts and related subfractions 2024 ·Acta Biomaterialia ·Andrea Acebes‐Huerta, (unknown), (unknown), (unknown), (unknown), (unknown), Antonio López‐Vázquez, Johannes A. Eble, Laura Gutiérrez	2
4	Rhomb-I, a P–I metalloproteinase from Lachesis muta rhombeata venom degrades vessel extra cellular matrix components and impairs platelet aggregation 2023 ·Toxicon ·(unknown), (unknown), (unknown), (unknown), Márcia Helena Borges, (unknown), Johannes A. Eble, Ana M. Moura‐da‐Silva, Eladio F. Sánchez	1
5	Multiparametric chemical exchange saturation transfer MRI detects metabolic changes in breast cancer following immunotherapy 2023 ·Journal of Translational Medicine ·(unknown), (unknown), Carsten Höltke, Jens Soltwisch, Stephan Niland, (unknown), Klaus Bergander, (unknown), Christiane Geyer, (unknown), Johannes A. Eble, Thomas J. Vogl, Johannes Roth, Walter Heindel, (unknown), Anne Helfen, Cornelius Faber, Moritz Wildgruber, Mirjam Gerwing, Verena Hoerr	6
6	Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon 2023 ·Blood Advances ·A. A. Martyanov, (unknown), (unknown), (unknown), (unknown), Anastasia A. Ignatova, E. M. Koltsova, (unknown), Н. А. Подоплелова, (unknown), (unknown), Галина Новичкова, Johannes A. Eble, Mikhail A. Panteleev, Dmitrii V. Kalinin, Anastasia N. Sveshnikova	6
7	Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists 2023 ·Communications Biology ·(unknown), (unknown), (unknown), Ying Di, Xueqing Wang, Malou Zuidscherwoude, (unknown), Deirdre M. Kavanagh, Johan Hummert, Johannes A. Eble, Bernhard Nieswandt, David Stegner, Alice Y. Pollitt, Dirk‐Peter Herten, Michael G. Tomlinson, Ángel Galindo García, Steve P. Watson	6
8	Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist 2022 ·Thrombosis and Haemostasis ·(unknown), Ying Di, (unknown), (unknown), María N. Barrachina, (unknown), (unknown), Todd H. Mize, Johannes A. Eble, (unknown), Alice Y. Pollitt, Marı́a Isabel Loza, Eduardo Domínguez, Steve P. Watson, Ángel Galindo García	6
9	What does it take to be a collagen receptor? 2022 ·Matrix Biology ·Richard W. Farndale, Arnoud Sonnenberg, C. Michael DiPersio, Johannes A. Eble, Jyrki Heino, Donald Gullberg	7
10	Dissecting platelet proteomics to understand the pathophysiology of immune thrombocytopenia: studies in mouse models 2022 ·Blood Advances ·(unknown), Marjolein Meinders, Iris M. De Cuyper, Johannes A. Eble, John W. Semple, Laura Gutiérrez	8
11	Experimental validation of computerised models of clustering of platelet glycoprotein receptors that signal via tandem SH2 domain proteins 2022 ·PLoS Computational Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jeremy A. Pike, Ying Di, Natalie S. Poulter, Alexandre Slater, Bodo Lange, Bernhard Nieswandt, Johannes A. Eble, Michael G. Tomlinson, Dylan M. Owen, David Stegner, Lloyd Bridge, Christoph Wierling, Steve P. Watson	4
12	A fibrinolytic snake venom metalloproteinase, mutalysin-II, with antiplatelet activity and targeting capability toward glycoprotein GPIbα and glycoprotein GPVI 2021 ·Biochimie ·Eladio F. Sánchez, (unknown), (unknown), Débora L. Oliveira, Maria Inácia Estevão-Costa, Renzo Flores-Ortiz, Johannes A. Eble	9
13	Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα 2019 ·Blood Advances ·(unknown), Knut Fälker, Elizabeth J. Haining, Maarten Criel, Madelene Lindkvist, Rubén Barroso, Peter Påhlsson, Liza U. Ljungberg, (unknown), G. Ed Rainger, Stephanie Watson, Johannes A. Eble, Marc Hoylaerts, Jonas Emsley, Peter Konradsson, Steve P. Watson, Yi Sun, Magnus Grenegård	21
14	Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis 2018 ·Blood ·Mitchell J. Geer, Johanna P. van Geffen, (unknown), Timo Vögtle, Christopher W. Smith, Silke Heising, Marijke J. E. Kuijpers, Bibian M. E. Tullemans, Gavin E. Jarvis, Johannes A. Eble, Mark Jeeves, Michael Overduin, Johan W. M. Heemskerk, Alexandra Mazharian, Yotis A. Senis	17
15	A novel fibrinolytic metalloproteinase, barnettlysin-I from Bothrops barnetti (barnett´s pitviper) snake venom with anti-platelet properties 2015 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Eladio F. Sánchez, Michael Richardson, Luiza Helena Gremski, Sílvio Sanches Veiga, Armando Yarlequé, Stephan Niland, Augusto Martins Lima, Maria Inácia Estevão-Costa, Johannes A. Eble	34
16	The Polarity Protein Scrib Is Essential for Directed Endothelial Cell Migration 2013 ·Circulation Research ·Uwe Michaelis, Emmanouil Chavakis, Christoph Kruse, Benno Jungblut, David Kaluza, (unknown), Yosif Manavski, Heinrich Heide, Marie-Josée Santoni, Michael Potente, Johannes A. Eble, Jean‐Paul Borg, Ralf P. Brandes	44
17	Collagen XXIII, Novel Ligand for Integrin α2β1 in the Epidermis 2011 ·Journal of Biological Chemistry ·Guido Veit, Daniela Zwolanek, Beate Eckes, Stephan Niland, Jarmo Käpylä, Manon C. Zweers, (unknown), Thomas Krieg, Jyrki Heino, Johannes A. Eble, Manuel Koch	34
18	CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis 2009 ·Blood ·Frauke May, Ina Hagedorn, Irina Pleines, Markus Bender, Timo Vögtle, Johannes A. Eble, Margitta Elvers, Bernhard Nieswandt	163
19	Decorin Regulates Endothelial Cell Motility on Collagen I through Activation of Insulin-like Growth Factor I Receptor and Modulation of α2β1 Integrin Activity 2008 ·Journal of Biological Chemistry ·Lorna R. Fiedler, Elke Schönherr, Rachel J. Waddington, Stephan Niland, Daniela G. Seidler, Daniel Aeschlimann, Johannes A. Eble	86
20	Cell Adhesion Experiments With Cell Lines Derived From Uveal Melanomas With Monosomy 3 2005 ·Investigative Ophthalmology & Visual Science ·(unknown), J. Rauterberg, (unknown), Johannes A. Eble, Gerasimos Anastassiou	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact